ClinicalTrials.Veeva

Menu

Role of Andi-d in Dengue Fever: a Pilot Study

P

Post Graduate Institute of Medical Education and Research, Chandigarh

Status

Completed

Conditions

Dengue Fever

Treatments

Drug: anti-d

Study type

Interventional

Funder types

Other

Identifiers

NCT01443247
dengue fever pgimer trial

Details and patient eligibility

About

The purpose of this study is evaluate the role of anti-d in dengue fever.

Full description

This study was conducted in pgimer. Patients presenting with fever and thrombocytopenia in emergency medical opd / medicine opd were screened and all dengue serology positive patients were evaluated for enrolment into the study. We had proposed to enroll 30 patients with diagnosed dengue haemorrhagic fever. the diagnosis of the dengue fever was based upon the clinical history ,general physical examination and the lab tests : thrombocytopenia ( platelet count ≤ 20,000 ) ,and a positive dengue serology.

STUDY DESIGN : It was an open label inteventional study . one group of 15 patients ( intervention group ) received platelet support along with injection anti-d in a dose of 50 µg/kg (250IU/kg) intravenously while the other group of 15 ( control group) received platelet support only . a base line platelet count of all the participant of both the study groups was taken and then the level of platelets at 12 , 24 , 36 , and 48hr post treatment initiation was noted. The patients were followed till the time of discharge .

Enrollment

30 patients

Sex

All

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • fever and thrombocytopenia with/without bleeding manifestations
  • dengue serology positive patients
  • platelet count ≤ 20,000/mm3
  • Rh positive patients
  • willing to give written informed consent

Exclusion criteria

  • dengue serology positive but platelet count > 20,000/mm3
  • Rh negative patients
  • pregnant females

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

30 participants in 2 patient groups

platelet support + anti-d
Experimental group
Treatment:
Drug: anti-d
platelet support
No Intervention group
Treatment:
Drug: anti-d

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems